The Patent Finder

Terms ending in 2031

Celeniv Pte. Ltd.

Every in-force patent on Celeniv Pte. Ltd.'s record whose computed term ends in 2031, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 9,200,253Method of Producing Erythrocytes
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 8,926,964Methods of Generating Natural Killer Cells
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 9,121,007Treatment of Bone-Related Cancers Using Placental Stem Cells
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
US 8,969,315Enhancement of Placental Stem Cell Potency Using Modulatory RNA Molecules
In force
 · High confidence
Celeniv Pte. Ltd.In forceHigh confidence
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited